🇺🇸 FDA
Patent

US 10300027

Effective sensitizing dose of a gelled immunomodulating topical composition

granted A61KA61K31/122A61K47/10

Quick answer

US patent 10300027 (Effective sensitizing dose of a gelled immunomodulating topical composition) held by Phio Pharmaceuticals Corp. expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Phio Pharmaceuticals Corp.
Grant date
Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/122, A61K47/10, A61K47/14, A61K47/26